Indapamide Aurobindo (Indapamide)

Indapamide works by blocking the Na⁺/Cl⁻ cotransporter in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary loss of these ions along with water. The resulting reduction in extracellular fluid volume lowers cardiac preload and peripheral vascular resistance, thereby decreasing blood pressure.

The appropriate dose of indapamide is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Dosage information is provided on the prescription label and should be followed exactly as directed by the prescriber.

Safety of indapamide in pregnancy or while breastfeeding has not been definitively established. Healthcare providers will weigh potential benefits against possible risks before prescribing it to pregnant or nursing women. Patients should discuss their specific situation with their doctor to determine the most appropriate therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class and offers a longer duration of action with a lower incidence of metabolic disturbances compared with some traditional thiazides. It is often chosen for patients who need effective blood‑pressure control combined with modest diuretic effect, especially when potassium‑sparing properties are desired.

Indapamide Aurobindo tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight, and excessive heat to maintain product stability and potency throughout its shelf life.

Indapamide Aurobindo is taken orally, usually as a single tablet once daily. It should be swallowed whole with a glass of water and can be taken with or without food, unless the prescribing physician provides specific instructions regarding timing with meals.

Serious risks include severe dehydration, hyponatremia, significant electrolyte disturbances such as hypokalemia, and rare cases of acute kidney injury. Patients should be monitored for signs of excessive fluid loss, sudden drops in blood pressure, or abnormal laboratory values, and seek medical attention if these occur.

Indapamide is contraindicated in individuals with known hypersensitivity to indapamide or other sulfonamide‑derived drugs. It should also be avoided in patients with severe renal impairment, uncontrolled electrolyte imbalances, or those who are currently taking medications that may cause dangerous interactions, such as lithium, without close medical supervision.